Scilex Holding Company (SCLX) investor relations documents from the company's IR site: 1 presentation, 1 press release; latest deck 2025-05-16. Read in-app with summaries. First-party data.
https://www.scilexholding.com/wp-content/uploads/2025/05/Scilex-Holding-non-confidential-deck.pdf: Scilex Holding Company (SCLX) is a biopharmaceutical firm developing non-opioid pain therapeutics and KDS2010 for obesity and neurodegenerative diseases.
| Published | Type | Document |
|---|---|---|
| 2025-05-16 | Presentation | https://www.scilexholding.com/wp-content/uploads/2025/05/Scilex-Holding-non-confidential-deck.pdf |
| 2024-03-27 | Press release | Scilex Holding Company Anounces thathe U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorento to its Stockholders as a Dividend Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend |
SCLX overview · SCLX earnings · SCLX financials · SCLX KPIs · SCLX ownership · SCLX peers · SCLX filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.